Invisible. Intuitive. Improved.
The St. Jude Medical™ Invisible Trial System with BurstDR™ Stimulation provides an intuitive way for you and your patients to evaluate spinal cord stimulation (SCS) therapy for managing chronic pain, and for you to help more patients stay in therapy longer by moving from trial to permanent implant. With new BurstDR™ stimulation,* you can offer your patients superior pain relief from overall pain and a reduction in back and leg pain, as compared to tonic stimulation.1,2
91% of patients were more willing to proceed with trial if it was with the St. Jude Medical™ Invisible Trial System.3
Contact a St. Jude Medical representative today to see how our trial system, along with the Proclaim™ Elite SCS system, can help you bring awareness of SCS and BurstDR stimulation to more patients.
Now with BurstDR™ stimulation
If you have patients who have not had success with SCS therapy in the past, new BurstDR stimulation* offers a new opportunity for pain relief. BurstDR stimulation is novel waveform proven to deliver superior pain relief over conventional tonic stimulation.1,2 It works by emulating natural firing patterns in the brain and is believed to modulate both the sensory and emotional pathways3—providing patients potential relief from their physical pain, as well as the suffering** associated with the pain.1,2
Virtually invisible for easy, out-of-the-way therapy
By eliminating external cables and incorporating Apple‡ mobile digital devices and Bluetooth®‡ wireless technology, our trial system is easier and less burdensome for patients to use—giving them the ability to focus on evaluating SCS therapy instead of managing the system.
Move more patients from pain to relief
The St. Jude Medical™ Invisible Trial System with BurstDR™ Stimulation is part of our spinal cord stimulation (SCS) portfolio. Our vision is to transform the management of chronic pain by offering advanced technologies designed to improve patient outcomes and experience to bring the benefits of SCS to more patients. Read more about the portfolio and our approach to chronic pain management.